Panacea Journal of Medical Sciences

---

Prevalence of thrombocytopenia among Indian patients who are on chemotherapeutic drugs in five cities of India: A cross sectional descriptive study

Full Text PDF Share on Facebook Share on Twitter

---

Original Article

Author Details : Parmila Malik, Mahendra Kumar Verma*, Jyotsana Khattri, Veeresh VG, Atul Khajuria, Lalit Singh

Volume : 13, Issue : 3, Year : 2023

Article Page : 736-740

https://10.18231/j.pjms.2023.135

Suggest article by email

---

Abstract

Background: Chemotherapeutic drugs are chemical drugs used in management of cancer, these drugs are chemotoxic and has varied number of adverse effects. Thrombocytopenia is one such adverse effect, thrombocytopenia is the condition in which the platelets counts are less than few lakhs and cause the symptoms of the bleeding. The present study desiged to find the prevalence of thrombocytopenia among Indians who are on chemotherapeutic drugs.
Materials and Methods: a descriptive cross section survey design used to identify the prevalence rate of thrombocytopenia among patients who are on chemotherapeutic drugs in India the cities studied are Lakhimpur 268 patients, Panipat 357 patients, Sonipat 384 patients, Gohana 291 patients, Delhi 445 patients, a total 1745 patients were under chemotherapeutic drugs of which 281 patients developed thrombocytopenia, in the samples collected analyzed at various selected diagnostic centers.
Results: The present study found that in Lakhimpur for 268 patients on chemotherapy 37 patients samples developed thrombocytopenia, Panipat for 357 patients on chemotherapy 76 patients samples developed thrombocytopenia, Sonipat for 384 patients on chemotherapy 68 patients samples developed thrombocytopenia, Gohana for 291 patients on chemotherapy 32 patients samples developed thrombocytopenia and in Delhi for 445 patients on chemotherapy 68 patients samples developed
thrombocytopenia respectively. The overall prevalence of thrombocytopenia among patients who are on chemotherapeutic drugs is 16.01%.
Conclusion: Chemo drugs are vital in management of cancer conditions, these drugs are best currently known in reducing or killing the cancer cells, however they also carry a bag of adverse effects which hampers the wellbeing of patients hence, the knowledge and prevalence rate of thrombocytopenia in patients under chemotherapy plays a vital role in primordial prevention and better management of thrombocytopenia in its occurrence..

Keywords: Chemo drug induced thrombocytopenia, Chemotherapy drugs and thrombocytopenia

How to cite : Malik P, Verma M K, Khattri J, Veeresh Vg, Khajuria A, Singh L, Prevalence of thrombocytopenia among Indian patients who are on chemotherapeutic drugs in five cities of India: A cross sectional descriptive study. Panacea J Med Sci 2023;13(3):736-740

Copyright © 2023 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)